• 20 October 2011

    Servier partners Miragen to develop microRNA-targeting drugs

    European pharmaceutical company, Les Laboratoires Servier, has entered into a partnership agreement with Miragen Therapeutics, for advancing the research, development and commercialisation of three microRNA-targeting drugs for cardiovascular diseases, including...

  • 18 October 2011

    Galenica submits Injectafer NDA to FDA

    Galenica's US partner Luitpold Pharmaceuticals has submitted a New Drug Application (NDA) with the US Food and Drug Administration (FDA) for Injectafer, used to treat iron deficiency anaemia.

  • 18 October 2011

    Roche to acquire Anadys

    Roche has signed a definitive merger agreement to acquire Anadys Pharmaceuticals, a manufacturer of antiviral drug compunds, for a total cash consideration of approximately $230m.

  • 18 October 2011

    ChemoCentryx commences CCX168 drug trial

    ChemoCentryx has initiated a Phase II clinical trial for CCX168, an orally-administered small molecule for the treatment of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV).